No profile data available.
LadRx Corporation (LADX) is a healthcare company in the additional cancer treatment drugs industry, based in Los Angeles, United States, with about 2 full-time employees.
It reported revenue of $0 for fiscal year 2024, and net income of -$1.59 million. In Q1 2025 (the quarter ended March 31, 2025) revenue was $0. Its market capitalization was $99 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.
LadRx reported $0 in revenue for fiscal year 2024. In Q1 2025 revenue was $0.
$99 as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Panbela Therapeutics, Inc. (PBLA), eFFECTOR Therapeutics, Inc. (EFTR), Kiromic BioPharma, Inc. (KRBPQ).